<DOC>
	<DOC>NCT00325715</DOC>
	<brief_summary>AGN 201904, a proton pump inhibitor, versus esomeprazole in the prevention of stomach or upper intestinal damage following administration of high-dose aspirin in healthy volunteers</brief_summary>
	<brief_title>AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Healthy Adult Volunteers who have provided written informed consent Volunteers with a history of upper gastrointestinal disease or who have a current diagnosis of upper gastrointestinal disease. Female volunteers who pregnant, nursing, or planning a pregnancy Volunteers with a history of drug or alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>